{"adverse event": 2.14, "agranulocytosis": 4.15, "blood cholesterol increased": 3.95, "blood thyroid stimulating hormone increased": 7.4, "blood triglycerides increased": 3.61, "cardiac failure": 4.18, "death": 6.81, "decreased appetite": 2.24, "dementia": 3.48, "dermatitis allergic": 3.15, "dermatitis exfoliative": 22.81, "dermatitis exfoliative generalised": 26.95, "disease progression": 2.95, "drug eruption": 23.0, "drug reaction with eosinophilia and systemic symptoms": 24.62, "dry skin": 3.51, "dysphagia": 3.83, "eczema": 3.38, "eosinophil count increased": 8.77, "erythema multiforme": 13.28, "fall": 3.1, "hospitalisation": 2.19, "hot flush": 7.92, "hypertension": 2.75, "hypothyroidism": 10.58, "interstitial lung disease": 10.83, "metastases to bone": 12.33, "metastases to lymph nodes": 6.27, "neoplasm malignant": 3.35, "oedema peripheral": 2.66, "prescribed underdose": 7.48, "prostate cancer": 52.97, "prostate cancer metastatic": 186.95, "prostatic specific antigen increased": 66.44, "pruritus": 2.21, "rash": 17.29, "rash erythematous": 4.5, "rash maculo-papular": 17.34, "rash papular": 3.07, "rash pruritic": 9.42, "seizure": 2.1, "skin disorder": 2.69, "skin exfoliation": 4.72, "skin reaction": 6.6, "skin toxicity": 9.96, "stevens-johnson syndrome": 17.53, "surgery": 2.48, "therapeutic product effect incomplete": 3.45, "toxic epidermal necrolysis": 30.02, "toxic skin eruption": 7.29, "treatment noncompliance": 5.52, "urinary retention": 2.34}